Patents by Inventor Mohammad Al Hreebat

Mohammad Al Hreebat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral dosage forms of ibrutinib
    Patent number: 11433072
    Abstract: Stable and bioavailable oral dosage forms of ibrutinib, the dosage forms comprising ibrutinib and an acidifying agent. The dosage forms can further comprise a binder, such as sodium alginate, a surfactant, a lubricant, a filler and/or a disintegrant. Methods of treating cancers, particularly blood cancers, and graft versus host disease comprising administering to a patient in need thereof a dosage form comprising ibrutinib and an acidifying agent.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: September 6, 2022
    Assignee: HIKMA PHARMACEUTICALS USA, INC.
    Inventors: Mahmoud Ghannam, Shahin Fesharaki, Mohammad Al Hreebat, Ahmad Arif Mohammad